Notably, even early treatment of hAPP-J20 mice with a BACE1 inhibitor did not prevent their network dysfunction or cognitive decline, although this intervention prevented the formation of amyloid plaques, as well as plaque associated microgliosis, and markedly reduced Aβ oligomer levels in brain tissues (Johnson et al., 2020). Here, BACE1 is linked to Mental deterioration.